ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
287 hedge funds and large institutions have $5.34B invested in Intra-Cellular Therapies Inc. in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
18% more capital invested
Capital invested by funds: $4.55B → $5.34B (+$797M)
5% more funds holding
Funds holding: 273 → 287 (+14)
Holders
287
Holding in Top 10
11
Calls
$16.6M
Puts
$10.7M
Top Buyers
| 1 | +$37.3M | |
| 2 | +$36.7M | |
| 3 | +$36M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$31.6M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$31M |
Top Sellers
| 1 | -$210M | |
| 2 | -$63M | |
| 3 | -$47.9M | |
| 4 |
DM
Deerfield Management
New York
|
-$39.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37.3M |